A Turning Point for Cancer. Personalized Cancer Immunotherapy, March 5th

PETER MAY Chairman, Mount Sinai Boards of Trustees

MICHAEL MINIKES AN= JOSEPH PLUMERI Trustees, Mount Sinai Health System o= New York City

KENNETH=L. DAVIS, MD
President and CEO
Mount Sinai He=Ith System of New York City

PERSONALIZED CANCER
IMMUN=THERAPY

THURSDA=, MARCH 5, 2015
3:00 TO 5:00 PM

THE PALM BEACH COUNTRY CLUB
760 NORTH OCEAN BOULE=ARD
PALM BEACH, FLORIDA

NINA BHARDW=J, MD, PHD
Ward-Coleman Chair in Cancer Research

Scientifi= Director of the Vaccine and Cell Therapy Core Laboratory Icahn =chool of Medicine at Mount Sinai of New York City FULL BIO

JOSHUA BRODY, MD
Direc=or, Lymphoma Immunotherapy Program
Icahn School of Medicine at M=unt Sinai of New York City
FULL=BIO

STEVEN BURAKOFF, MD
Lillian and Henry M. Strat=on Professor of Cancer Medicine
Director, The Tisch Cancer Instit=te
Icahn School of Medicine at Mount Sinai of New York City<=r />FULL BIO

Kind=y RSVP by Friday, February 20th to
Rebecca Kane Solinsky a

If you do not wish to r=ceive email communication from us, click https://philanthro=y.mountain.org/page.aspx?pid=502&srctid=1&erid=456159&tr=d=b751cb25-8755-44ff-b25d-d34a8437731d